Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle



Rating:

Share or cite this content

Citations should be made in the following way:
F. Rahaghi (Boston, United States of America), V. Paz (Weston, United States of America), P. Nardelli (Boston, United States of America), J. Ross (Boston, United States of America), R. San José Estépar (Boston, United States of America), G. Washko (Boston, United States of America), F. Rahaghi (Boston, United States of America). CT Based Arterial and Venous Morphologic Changes In Pulmonary Hypertension Associated with COPD. 3105

Member's Comments

No comment yet.

Related content which might interest you: A Minimal Clinically Important Difference for CAMPHOR in Idiopathic Pulmonary Arterial Hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Clinical Features of Pulmonary Hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Contribution of BMP9 to Pulmonary Arterial Hypertension Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension Year: 2017 Exercise-induced pulmonary pressure changes in scleroderma patients – A follow-up study Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange Year: 2014 Non-invasive cardiac output assessment in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Microvascular Endothelial Function in treated Pulmonary Arterial Hypertension Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Role of CHK1 in Pulmonary Arterial Hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Noninvasive Arterial Stiffness Measurement in Patients with Sarcoidosis Source: International Congress 2017 – Novel and old entities Year: 2017 Cerebral tissue oxygenation in arterial and thromboembolic pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Pulmonary arterial hypertension – A single-centre experience Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Relevance of echocardiographic composite index to improve the detection of pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Immune signatures in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Nebivolol and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Alteration of factors associated with coagulation in provoked pulmonary embolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014